Materias dentro de su búsqueda.
Mostrando 41 - 60 Resultados de 110,380 Para Buscar '"Lu'an"', tiempo de consulta: 1.01s Limitar resultados
  1. 41
    “…This study sought to elucidate the efficacy and safety of [(177)Lu]Lu-DOTATATE in NENs with different locations and evaluate the effect of the tumor origin, bearing in mind other prognostic variables. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of [(177)Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
  2. 42
    “…Over the past few decades, several bone-seeking radiopharmaceuticals including various bisphosphonate ligands and β-emitting radionuclides have been developed for bone pain palliation. Recently, (177)Lu was successfully labeled with zoledronic acid ((177)Lu-ZLD) as a new generation potential bisphosphonate and demonstrated significant accumulation in bone tissue. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats
  3. 43
    “…In this study, patients with significantly impaired baseline kidney function before initiation of therapy were investigated for treatment-associated nephrotoxicity and the potential relationship with administered activities of [(177)Lu]Lu-PSMA-617. Methods: Twenty-two mCRPC patients with impaired renal function (glomerular filtration rate (GFR) ≤ 60 mL/min) who received more than two cycles of [(177)Lu]Lu-PSMA-617 RLT (median 5 cycles and median 6-week time interval between consecutive cycles) were analyzed in this study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Renal Safety of [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function
  4. 44
    “…Here, we investigate the influence that earlier cycles of [(177)Lu]Lu-DOTATATE had on the biokinetics and AD of subsequent cycles in a recent clinical trial that evaluated the safety and activity of [(177)Lu]Lu-DOTATATE in pediatric neuroblastoma (NBL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [(177)Lu]Lu-DOTATATE
  5. 45
    “…BACKGROUND: [(177)Lu]Lu-PSMA is used for the treatment of metastatic castration-resistant prostate cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Quality control of [(177)Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery
  6. 46
    por Hennrich, Ute, Eder, Matthias
    Publicado 2022
    “…In March 2022, [(177)Lu]Lu-PSMA-617 (Pluvicto(TM)) was approved by the FDA for the treatment of prostate cancer patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    [(177)Lu]Lu-PSMA-617 (Pluvicto(TM)): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
  7. 47
    “…In this study, we investigated molecular imaging and biochemical responses after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in patients who had progressed on [(177)Lu]Lu-PSMA-617 monotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molecular imaging and biochemical response assessment after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [(177)Lu]Lu-PSMA-617 monotherapy
  8. 48
    “…The solubility of Lu within the system was found to be quite low with x(max) ∼ 0.3; samples with x > 0.3 contained impurities of LuSb. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Lu-Substitution in Yb(14–x)Lu(x)ZnSb(11): Thermoelectric Properties and Oxidation Studies
  9. 49
    “…In recent years, [(177)Lu]Lu-DOTA-TATE has begun to be widely used for the treatment of neuroendocrine tumours. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Radiation exposure assessment of nuclear medicine staff administering [(177)Lu]Lu-DOTA-TATE with active and passive dosimetry
  10. 50
    “…BACKGROUND: In this work, a lutetium-177 ((177)Lu) production method based on the separation of nuclear isomers, (177m)Lu & (177)Lu, is reported. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Radionuclide generator-based production of therapeutic (177)Lu from its long-lived isomer (177m)Lu
  11. 51
    “…BACKGROUND: Preclinical biodistribution and dosimetric analysis of [(177)Lu]Lu-DOTA(ZOL) suggest the bisphosphonate zoledronate as a promising new radiopharmaceutical for therapy of bone metastases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biodistribution and post-therapy dosimetric analysis of [(177)Lu]Lu-DOTA(ZOL) in patients with osteoblastic metastases: first results
  12. 52
    “…The results highlighted some important quality issues of the final preparation: radiolabeling of PSMA-I&T with lutetium-177 needs a considerably longer time compared with the radiolabeling of the well-known [(177)Lu]Lu-PSMA-617. When the final product was formulated in saline, the stability of [(177)Lu]Lu-PSMA-I&T was reduced by radiolysis, showing a decrease in radiochemical purity (<95% in 24 h). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Production and Quality Control of [(177)Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials
  13. 53
    por Roig, O
    Publicado 2010
    “…The DANCE (Detector for Advanced Neutron Capture Experiments) array located at the Los Alamos national laboratory has been used to obtain the neutron capture cross sections for 175Lu and 176Lu with neutron energies from thermal up to 100 keV. …”
    Enlace del recurso
    Neutron capture reactions on Lu isotopes at DANCE
  14. 54
    por Prisciandaro, Jessica
    Publicado 2016
    Enlace del recurso
    New results in LU/LFV tests with LHCb
  15. 55
    por Prisciandaro, Jessica
    Publicado 2017
    Enlace del recurso
    Enlace del recurso
    New results in LU/LFV tests with LHCb
  16. 56
    por Hinfurtner, B, Hagn, E, Zech, E, Eder, R, Kern, J
    Publicado 1991
    Enlace del recurso
    Enlace del recurso
    No anomaly of the magnetic moment of $^{174m}$Lu
  17. 57
    Enlace del recurso
    Enlace del recurso
    Industrial growth of LuYAP scintillation crystals
  18. 58
    Enlace del recurso
    Texto
    Organic Diets: Lu et al. Respond
  19. 59
    “…Materials and Methods: Lu-177 of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu(2)O(3 )sample with thermal neutron flux of 4 × 10(13) n.cm(-2).s(-1). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of (177)Lu-phytate Complex for Radiosynovectomy
  20. 60
    “…PURPOSE: Lutetium Lu-177 dotatate is the first peptide receptor radionuclide therapy approved by the US Food and Drug Administration. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lutetium Lu-177 Dotatate Flare Reaction
Herramientas de búsqueda: RSS